The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohort

EuroIntervention 2017;13:796-803 published online May 2017. DOI: 10.4244/EIJ-D-16-01025

1. Clinique Pasteur, Toulouse, France; 2. MonashHEART, Monash Health & Monash University, Melbourne, Australia; 3. The General Infirmary, Leeds, United Kingdom; 4. Sussex Cardiac Centre, Brighton and Sussex University Hospitals, Brighton, United Kingd

Aims: This analysis aimed to evaluate the incidence and predictors of the need for permanent pacemaker (PPM) implantation following implantation of the repositionable and fully retrievabl

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Impact of pulmonary hypertension on in-hospital outcome after surgical or transcatheter aortic valve replacement

Latest news